IP Library Assignment 021630/0352
Patent Assignment
Reel/Frame 021630/0352

Security Agreement

Recorded: 2008-10-03 Pages: 11
Assignor
UNIGENE LABORATORIES, INC.
Executed: 2008-09-30
Assignee
VICTORY PARK MANAGEMENT, LLC
227 W. MONROE STREET, SUITE 3900, CHICAGO, ILLINOIS, 60606
Covered Properties (38)
Alpha-Amidating Enzyme Compositions and Processes for Their Production and Use
Patent: 6,319,685 →
Application: 07/086,161 →
Expression Systems for Amidating Enzyme
Patent: 5,789,234 →
Application: 07/307,366 →
Oral Salmon Calcitonin Pharmaceutical Products
Patent: 5,912,014 →
Application: 08/616,250 →
Direct Expression of Peptides into Culture Media
Patent: 6,103,495 →
Application: 09/060,765 →
Oral Peptide Pharmaceutical Products
Patent: 6,086,918 →
Application: 09/125,500 →
Direct expression of peptides into culture media
Patent: 6,210,925 →
Application: 09/500,009 →
Nasal Calcitonin Formulations
Patent: 6,440,392 →
Application: 09/776,537 →
Direct Expression of Peptides into Culture Media
Patent: 6,737,250 →
Application: 09/780,643 →
Publication: US 2002/0045211
Direct Expression of Peptides into Culture Media
Patent: 6,627,438 →
Application: 09/780,878 →
Publication: US 2001/0055789
Oral Delivery of Peptides Using Enzyme-Cleavable Membrane Translocators
Patent: 6,673,574 →
Application: 09/997,465 →
Publication: US 2003/0118610
Oral Peptide Pharmaceutical Dosage Form and Method of Production
Patent: 7,316,819 →
Application: 10/094,306 →
Publication: US 2003/0017203
Hybrid Molds for Molten Solder Screening Process
Patent: 6,832,747 →
Application: 10/128,210 →
Publication: US 2002/0125402
Oral Delivery of Peptides
Patent: 8,088,734 →
Application: 10/761,481 →
Publication: US 2004/0197323
Nasal Calcitonin Formulation
Patent: 40,812 →
Application: 10/774,358 →
Direct Expression of Peptides into Culture Media
Patent: 7,968,311 →
Application: 10/818,966 →
Publication: US 2004/0191865
Amidated parathyroid hormone fragments and uses thereof
Application: 11/040,557 →
Publication: US 2005/0215476
Bacterial Host Cell for the Direct Expression of Peptides
Patent: 8,227,241 →
Application: 11/076,260 →
Publication: US 2005/0221442
Method for Fostering Bone Formation and Preservation
Patent: 7,531,518 →
Application: 11/128,095 →
Publication: US 2005/0256047
Oral delivery of peptide pharmaceutical compositions
Application: 11/144,580 →
Publication: US 2005/0282756
Method for bone augmentation
Application: 11/254,640 →
Publication: US 2006/0089723
Method for Fostering Bone Formation and Preservation
Patent: 7,648,965 →
Application: 11/267,987 →
Publication: US 2006/0094656
Enzymatic Reactions in the Presence of Keto Acids
Patent: 7,445,911 →
Application: 11/285,136 →
Publication: US 2006/0127995
Bone implant device and methods of using same
Application: 11/430,752 →
Publication: US 2006/0293667
Amidated parathyroid hormone fragments and uses thereof
Application: 11/455,628 →
Publication: US 2006/0270603
Cell lines for expressing enzyme useful in the preparation of amidated products
Patent: 8,815,583 →
Application: 11/474,159 →
Publication: US 2006/0292672
Fast-Acting Oral Peptide Pharmaceutical Products
Patent: 8,093,207 →
Application: 11/567,454 →
Publication: US 2007/0134279
Method for Detecting the Presence of Glycine Containing Compounds
Application: 11/654,211 →
Publication: US 2007/0254328
Methods and Compositions for Fostering and Preserving Bone Growth
Patent: 8,852,240 →
Application: 11/796,439 →
Publication: US 2008/0213333
Method for Fostering Bone Formation and Preservation
Patent: 7,648,700 →
Application: 11/839,957 →
Publication: US 2008/0057051
Method for Fostering Bone Formation and Preservation
Application: 11/839,993 →
Publication: US 2008/0051343
Bacterial Host Cell for the Direct Expression of Peptides
Patent: 8,216,822 →
Application: 11/928,936 →
Publication: US 2008/0057566
Bacterial Host Cell for the Direct Expression of Peptides
Patent: 8,252,580 →
Application: 11/928,994 →
Publication: US 2008/0102491
Bacterial Host Cell for the Direct Expression of Peptides
Patent: 7,541,174 →
Application: 11/929,028 →
Publication: US 2008/0102509
Bacterial Host Cell for the Direct Expression of Peptides
Patent: 7,553,655 →
Application: 11/929,079 →
Publication: US 2008/0102510
Method for Fostering Bone Formation and Preservation
Application: 12/059,605 →
Publication: US 2008/0183134
Method for Fostering Bone Formation and Preservation
Patent: 7,776,826 →
Application: 12/059,662 →
Publication: US 2008/0181880
Bone Augmentation Apparatus
Patent: 9,289,235 →
Application: 12/063,618 →
Publication: US 2008/0195114
Peptide Pharmaceutical for Oral Delivery
Application: 60/940,598 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 17, 2006
From: MEHTA, NOZER M.; STERN, WILLIAM; GILLIGAN, JAMES P.
To: UNIGENE LABORATORIES INC.
Reel/Frame 018104/0751 →
Re-Record to Correct the Serial Number on a Document Previously Recorded at Reel 016763, Frame 0349. (Assignment of Assignor's Interest) Jul 17, 2006
From: MEHTA, NOZER M.; STERN, WILLIAM; GILLIGAN, JAMES P.
To: UNIGENE LABORATORIES INC.
Reel/Frame 018103/0267 →
Release of Security Interest Jul 13, 2007
From: LEVY, JAY
To: UNIGENE LABORATORIES, INC.
Reel/Frame 019550/0483 →
Assignment of Security Interest Sep 28, 2007
From: LEVY, JAY
To: JAYNJEAN LEVY FAMILY LIMITED PARTNERSHIP
Reel/Frame 019892/0459 →
Amended and Restated Patent Security Agreement Oct 11, 2007
From: UNIGENE LABORATORIES, INC.
To: JAYNJEAN LEVY FAMILY LIMITED PARTNERSHIP
Reel/Frame 019943/0714 →
Executive Order 9424, Confirmatory License Jun 23, 2008
From: YALE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021139/0029 →
Release of Security Interest Oct 1, 2008
From: OLYMPUS SECURITIES, LTD.; NELSON PARTNERS, CITADEL INVESTMENT MANAGEMENT, L.P., CITADEL INVESTMENT MANAGEMENT, INC.
To: UNIGENE LABORATORIES, INC.
Reel/Frame 021603/0790 →
Release of Security Interest Sep 13, 2011
From: VICTORY PARK MANAGEMENT, LLC
To: UNIGENE LABORATORIES, INC.
Reel/Frame 026895/0797 →
Release of Security Interest Sep 7, 2012
From: VICTORY PARK MANAGEMENT
To: UNIGENE LABORATORIES, INC.
Reel/Frame 028913/0370 →
Assignment of Assignor's Interest Sep 12, 2012
From: STERN, WILLIAM
To: UNIGENE LABORATORIES INC.
Reel/Frame 028947/0938 →
Security Agreement Oct 4, 2012
From: UNIGENE LABORATORIES, INC.
To: VICTORY PARK MANAGEMENT, LLC, AS COLLATERAL AGENT
Reel/Frame 029074/0689 →
Assignment of Assignor's Interest Apr 26, 2013
From: UNIGENE LABORATORIES, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 030300/0538 →
Assignment of Assignor's Interest Jul 23, 2013
From: UNIGENE LABORATORIES, INC.
To: UGP THERAPEUTICS, INC.
Reel/Frame 030856/0340 →
Assignment of Assignor's Interest Sep 11, 2013
From: UGP THERAPEUTICS, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 031185/0455 →
Assignment of Assignor's Interest Mar 13, 2014
From: MEHTA, NOZER M.; CONSALVO, ANGELO P.; RAY, MARTHA V.L.; MEENAN, CHRISTOPHER P.
To: UNIGENE LABORATORIES, INC.
Reel/Frame 032434/0733 →
Assignment of Assignor's Interest Mar 13, 2014
From: MEHTA, NOZER M.; CONSALVO, ANGELO P.; RAY, MARTHA V.L.; MEENAN, CHRISTOPHER P.
To: UNIGENE LABORATORIES, INC.
Reel/Frame 032434/0281 →
Assignment of Assignor's Interest Mar 13, 2014
From: MEHTA, NOZER M.; CONSALVO, ANGELO P.; RAY, MARTHA V.L.; MEENAN, CHRISTOPHER P.
To: UNIGENE LABORATORIES, INC.
Reel/Frame 032434/0418 →
Assignment of Assignor's Interest Mar 13, 2014
From: UNIGENE LABORATORIES, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 032434/0431 →
Assignment of Assignor's Interest Mar 13, 2014
From: UNIGENE LABORATORIES, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 032434/0534 →
Assignment of Assignor's Interest Mar 17, 2014
From: MEHTA, NOZER M.; CONSALVO, ANGELO P.; RAY, MARTHA V.L.; MEENAN, CHRISTOPHER P.
To: UNIGENE LABORATORIES, INC.
Reel/Frame 032457/0801 →
Assignment of Assignor's Interest Jul 18, 2016
From: UNIGENE LABORATORIES, INC.
To: UGP THERAPEUTICS, INC.
Reel/Frame 039182/0406 →
Assignment of Assignor's Interest Jul 19, 2016
From: UGP THERAPEUTICS, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 039184/0797 →
Corrective Assignment to Correct the Nature of Conveyance Previously Recorded on Reel 039184 Frame 0797. Assignor(S) Hereby Confirms the Nunc Pro Tunc Assignment Effective 02/01/2016. Aug 15, 2016
From: UGP THERAPEUTICS, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 039682/0212 →
Release of Security Interest Aug 8, 2019
From: VICTORY PARK MANAGEMENT, LLC
To: UNIGENE LABORATORIES, INC.
Reel/Frame 050000/0799 →
Release of Security Interest Aug 8, 2019
From: VICTORY PARK MANAGEMENT, LLC
To: UNIGENE LABORATORIES, INC.
Reel/Frame 050000/0762 →